Chesnara Plc: Fourth acquisition in two years
12 November 2026
Myriad Genetics, Inc. (NASDAQ: MYGN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $479.7..
Bicycle Therapeutics plc (NASDAQ: BCYC) is capturing the attention of investors with its impressive potential upside of 251.40%, as indicated by analyst target prices. This United..
For investors with an appetite for high-risk, high-reward opportunities in the biotechnology sector, Abivax SA (ABVX) presents an intriguing proposition. Based in Paris, France, and boasting..
Trevi Therapeutics, Inc. (TRVI), a promising name within the biotechnology sector, has garnered significant attention with its innovative approach to treating chronic conditions. With a market..
PureTech Health plc (PRTC), a cutting-edge player in the biotechnology industry, has captured investor attention with a jaw-dropping 542.7% revenue growth, a testament to its dynamic..
Celcuity Inc. (NASDAQ: CELC) stands out in the biotechnology sector as an intriguing prospect for investors focused on innovative cancer treatments. With a current market capitalization..
CorMedix Inc. (CRMD), a promising player in the biotechnology sector, is grabbing attention with its significant upside potential and a robust lead product candidate, DefenCath. Based..
Auna SA (AUNA), a prominent player in the healthcare sector, is capturing investor attention with its significant potential upside. Based in Luxembourg and operating extensively in..
Simulations Plus, Inc. (SLP) stands as a prominent name in the healthcare sector, specifically within the health information services industry. As a developer of innovative drug..
Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in the development and commercialization of vaccines for infectious diseases, presents a compelling opportunity for investors seeking..
Claritev Corporation (NASDAQ: CTEV) is a compelling player in the healthcare sector, particularly within the Health Information Services industry. As a provider of innovative data analytics..
EyePoint, Inc. (NASDAQ: EYPT), a promising player in the biotechnology sector, is drawing significant attention from investors with a notable 135% potential upside, as indicated by..
SI-BONE, Inc. (NASDAQ: SIBN) is carving a niche in the healthcare sector, specifically within the medical devices industry. Headquartered in Santa Clara, California, this company engages..
Kura Oncology, Inc. (NASDAQ: KURA) stands out in the biotechnology sector as a promising clinical-stage biopharmaceutical company dedicated to developing innovative cancer treatments. With a market..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, California, is drawing considerable attention from investors, given its robust pipeline of immunology therapeutics..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) continues to capture the attention of investors in the biotechnology sector, largely due to its potential upside of 10.64%. With..
For investors eyeing the healthcare sector, SIGA Technologies Inc. (NASDAQ: SIGA) presents a unique opportunity. With a market cap of $446.85 million, this American-based company operates..
Investors eyeing the healthcare sector would do well to tune into Oruka Therapeutics, Inc. (NASDAQ: ORKA), a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for..
MBX Biosciences, Inc. (MBX) has captured the attention of investors with a compelling potential upside of 94.37%, according to the latest analyst ratings. This clinical-stage biopharmaceutical..
Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company headquartered in New Haven, Connecticut, is at the forefront of developing innovative therapies aimed at degrading disease-causing proteins...
